Literature DB >> 21600248

Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles.

Hideaki Nakamura1, Jun Fang, Bharate Gahininath, Kenji Tsukigawa, Hiroshi Maeda.   

Abstract

SMA-ZnPP and PEG-ZnPP are micellar drugs, encapsulating zinc protoporphyrin IX (ZnPP) with styrene maleic acid copolymer (SMA) and covalent conjugate of ZnPP with polyethylene glycol (PEG) respectively. Their intracellular uptake rate and subcellular localization were investigated. We found SMA-ZnPP showed higher and more efficient (about 2.5 times) intracellular uptake rate than PEG-ZnPP, although both SMA-ZnPP and PEG-ZnPP micelles were localized at endoplasmic reticulum (ER) and inhibited the target enzyme heme oxygenase 1 (HO-1) similarly. Both micellar ZnPP were taken up into the tumor cells by endocytosis. Furthermore SMA-ZnPP and PEG-ZnPP were examined for their drug releasing mechanisms. Liberation of ZnPP from the SMA micelle appears to depend on cellular amphiphilic components such as lecithin, while that for PEG-ZnPP depends on hydrolytic cleavage. These results indicate that these micelle formulations make water insoluble ZnPP to water soluble practical anticancer agents.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21600248     DOI: 10.1016/j.jconrel.2011.04.025

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  12 in total

1.  Role of heme oxygenase-1 in postnatal differentiation of stem cells: a possible cross-talk with microRNAs.

Authors:  Magdalena Kozakowska; Krzysztof Szade; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-01-30       Impact factor: 8.401

2.  HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases.

Authors:  Haruhiko Dozono; Shintaro Yanazume; Hideaki Nakamura; Tomáš Etrych; Petr Chytil; Karel Ulbrich; Jun Fang; Takeshi Arimura; Tsutomu Douchi; Hiroaki Kobayashi; Michiaki Ikoma; Hiroshi Maeda
Journal:  Target Oncol       Date:  2016-02       Impact factor: 4.493

Review 3.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

4.  Insights on how the Mycobacterium tuberculosis heme uptake pathway can be used as a drug target.

Authors:  Cedric P Owens; Nicholas Chim; Celia W Goulding
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

5.  Synthesis and characterization of mono-, di-, and tri-poly(ethylene glycol) chlorin e6 conjugates for the photokilling of human ovarian cancer cells.

Authors:  Stanley Kimani; Goutam Ghosh; Ashwini Ghogare; Benjamin Rudshteyn; Dorota Bartusik; Tayyaba Hasan; Alexander Greer
Journal:  J Org Chem       Date:  2012-11-14       Impact factor: 4.354

Review 6.  Gasotransmitters in cancer: from pathophysiology to experimental therapy.

Authors:  Csaba Szabo
Journal:  Nat Rev Drug Discov       Date:  2015-12-18       Impact factor: 84.694

7.  A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer.

Authors:  Sebastien Taurin; Hayley Nehoff; Thalita van Aswegen; Rhonda J Rosengren; Khaled Greish
Journal:  Biomed Res Int       Date:  2014-02-06       Impact factor: 3.411

8.  Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin.

Authors:  Kenji Tsukigawa; Long Liao; Hideaki Nakamura; Jun Fang; Khaled Greish; Masaki Otagiri; Hiroshi Maeda
Journal:  Cancer Sci       Date:  2015-02-03       Impact factor: 6.716

9.  Endogenous zinc protoporphyrin formation critically contributes to hemorrhagic stroke-induced brain damage.

Authors:  Rong Pan; Song Yu; Haikun Zhang; Graham S Timmins; John Weaver; Yirong Yang; Xixi Zhou; Ke Jian Liu
Journal:  J Cereb Blood Flow Metab       Date:  2021-06-29       Impact factor: 6.960

10.  EPR-Effect Enhancers Strongly Potentiate Tumor-Targeted Delivery of Nanomedicines to Advanced Cancers: Further Extension to Enhancement of the Therapeutic Effect.

Authors:  Waliul Islam; Shintaro Kimura; Rayhanul Islam; Ayaka Harada; Katsuhiko Ono; Jun Fang; Takuro Niidome; Tomohiro Sawa; Hiroshi Maeda
Journal:  J Pers Med       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.